Objectives: To identify preoperative risk factors for 90-day mortality and to validate existing nomograms in a multicenter series of patients undergoing radical cystectomy (RC). Materials and Methods: We evaluated 90-day mortality in 475 patients following RC and urinary diversion at 2 Italian institutions and validated Aziz and Isbarn nomogram. Univariable logistic models assessed the predictive ability of operative volume, age at intervention, gender, body mass index, carcinoma in situ at transurethral resection of the bladder, American Society of Anesthesiologist (ASA) score, Charlson Comorbidity Index, clinical stage and pathological stage (TNM). Results: Of the total number of patients, 387 of them (81%) were male. The median age at RC was 71.8. The most frequent ASA score was 2 (53%). Twenty-five deaths occurred within 90 days (5.3%), all among patients who had undergone RC and incontinent urinary diversion. Risk was higher in patients with advanced disease (OR 2.4); moreover, 90-day mortality odd in 70-79-year-old patients was 13 times higher than those of younger patients (<70). Predictive accuracy using Isbarn's and Aziz's nomogram were 67 and 71%, respectively. Conclusions: Our multicenter study confirmed the moderate predictive value of the Aziz nomogram. Larger studies are needed to improve on existing nomograms with the aim of enhancing preoperative counseling.

Keywords:
Nomogram , Mortality, Bladder cancer, Radical cystectomy, Urinary diversion
1.
Babjuk M, Burger M, Zigeuner R, et al: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013;64:639-653.
2.
Chang SS, Cookson MS, Baumgartner RG, et al: Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012-2016.
3.
Hollenbeck BK, Miller DC, Taub D, et al: Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174(4 pt 1):1231-1237; discussion 1237.
4.
Konety BR, Allareddy V, Herr H: Complications after radical cystectomy: analysis of population-based data. Urology 2006;68:58-64.
5.
Quek ML, Stein JP, Daneshmand S, et al: A critical analysis of perioperative mortality from radical cystectomy. J Urol 2006;175(3 pt 1):886-889; discussion 889-890.
6.
Studer UE, Burkhard FC, Schumacher M, et al: Twenty years experience with an ileal orthotopic low pressure bladder substitute - lessons to be learned. J Urol 2006;176:161-166.
7.
Novotny V, Hakenberg OW, Wiessner D, et al: Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 2007;51:397-401; discussion 401-402.
8.
Fairey A, Chetner M, Metcalfe J, et al: Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol 2008;180:128-134; discussion 134.
9.
Pycha A, Comploj E, Martini T, et al: Comparison of complications in three incontinent urinary diversions. Eur Urol 2008;54:825-832.
10.
Boström PJ, Kössi J, Laato M, et al: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009;103:191-196.
11.
Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55:164-174.
12.
Zakaria AS, Santos F, Dragomir A, et al: Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: a population-based analysis during the years 2000-2009. Can Urol Assoc J 2014;8:259-267.
13.
Comploj E, West J, Mian M, et al: Comparison of complications from radical cystectomy between old-old versus oldest-old patients. Urol Int 2015;94:25-30.
14.
Isbarn H, Jeldres C, Zini L, et al: A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 2009;182:70-77.
15.
Taylor JM, Feifer A, Savage CJ, et al: Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU Int 2012;109:855-859.
16.
Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, et al: Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163.
17.
Skinner DG, Lieskovsky G: Management of invasive high-grade bladder cancer; in Diagnosis and Management of Genitourinary Cancer. Philadelphia, WB Saunders Co., 1987, vol 1, pp 295-324.
18.
Pagano F, Artibani W, Ligato P, Piazza R, Garbeglio A, Passerini G: Vescica ileale padovana: a technique for total bladder replacement. Eur Urol 1990;17:149-154.
19.
Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
20.
Dripps RD, Lamont A, Eckenhoff JE: The role of anesthesia in surgical mortality. JAMA 1961;178:261-266.
21.
Clavien PA, Sanabria JR, Strasberg SM: Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518-526.
22.
Greene FL, Gospodarowicz M, Wittekend C, et al: American Joint Committee on Cancer (AJCC) Staging Manual, ed 7. Philadelphia, Springer, 2009.
23.
Novara G, De Marco V, Aragona M, et al: Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-921.
24.
Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55:164-174.
25.
Nieuwenhuijzen JA, de Vries RR, et al: Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 2008;53:834-844; discussion 842-844.
26.
Kim SH, Yu A, Jung JH, et al: Incidence and risk factors of 30-day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit. Jpn J Clin Oncol 2014;44:677-685.
27.
Schiffmann J, Gandaglia G, Larcher A, et al: Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol 2014;40:1738-1745.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.